CLINICAL_TRIALS
trial_result
· 2016-09-15
Clinical Trial Update: Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors [Phase 1]
Summary
A Phase I ascending multiple-dose study of BMS-986115 in subjects with advanced solid tumors was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Various Advanced Cancer | Phase 1 | Status: TERMINATED